X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (27214) 27214
Newspaper Article (8373) 8373
Newsletter (7430) 7430
Book Review (5044) 5044
Publication (1862) 1862
Magazine Article (499) 499
Conference Proceeding (484) 484
Trade Publication Article (386) 386
Book Chapter (134) 134
Transcript (120) 120
Web Resource (107) 107
Dissertation (43) 43
Book / eBook (15) 15
Paper (6) 6
Reference (4) 4
Government Document (2) 2
Data Set (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
statins (37807) 37807
index medicus (18269) 18269
humans (15952) 15952
cholesterol (14044) 14044
male (9647) 9647
cardiovascular disease (8958) 8958
female (8733) 8733
medical research (8387) 8387
research (7274) 7274
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (7056) 7056
middle aged (7054) 7054
aged (6298) 6298
risk factors (6228) 6228
studies (6046) 6046
cardiovascular agents (5979) 5979
heart attacks (5636) 5636
cardiac & cardiovascular systems (5557) 5557
drug therapy (5341) 5341
care and treatment (4740) 4740
atherosclerosis (4419) 4419
prevention (4123) 4123
medicine, experimental (4000) 4000
lipids (3791) 3791
analysis (3734) 3734
statin (3719) 3719
mortality (3718) 3718
statin therapy (3634) 3634
pharmacology & pharmacy (3623) 3623
simvastatin (3614) 3614
cardiovascular diseases (3574) 3574
atorvastatin (3511) 3511
risk (3385) 3385
treatment outcome (3373) 3373
adult (3317) 3317
low density lipoproteins (3287) 3287
diabetes (3248) 3248
animals (3161) 3161
coronary heart disease (3100) 3100
abridged index medicus (3086) 3086
reports (3038) 3038
health aspects (2930) 2930
hypercholesterolemia (2889) 2889
therapy (2867) 2867
peripheral vascular disease (2718) 2718
cardiac patients (2608) 2608
cardiovascular (2506) 2506
cardiology (2496) 2496
drugs (2485) 2485
coronary-heart-disease (2454) 2454
medicine, general & internal (2444) 2444
inflammation (2380) 2380
hydroxymethylglutaryl-coa reductase inhibitors - pharmacology (2347) 2347
clinical trials (2344) 2344
low density lipoprotein (2335) 2335
c-reactive protein (2256) 2256
cholesterol, ldl - blood (2207) 2207
dosage and administration (2102) 2102
stroke (2065) 2065
patients (2045) 2045
disease (2019) 2019
cardiovascular-disease (1997) 1997
hydroxymethylglutaryl-coa reductase inhibitors - adverse effects (1955) 1955
hydroxymethylglutaryl-coa reductase inhibitors - administration & dosage (1932) 1932
pravastatin (1906) 1906
metaanalysis (1814) 1814
myocardial-infarction (1807) 1807
internal medicine (1782) 1782
aged, 80 and over (1757) 1757
atorvastatin calcium (1719) 1719
health risk assessment (1712) 1712
cardiovascular diseases - prevention & control (1701) 1701
hypertension (1691) 1691
cancer (1668) 1668
hypercholesterolemia - drug therapy (1623) 1623
usage (1592) 1592
anticholesteremic agents - therapeutic use (1564) 1564
retrospective studies (1548) 1548
medicine & public health (1527) 1527
antilipemic agents (1464) 1464
medicine (1464) 1464
time factors (1464) 1464
complications and side effects (1396) 1396
lipoproteins (1338) 1338
rosuvastatin (1318) 1318
universities and colleges (1313) 1313
drug therapy, combination (1311) 1311
prospective studies (1301) 1301
acute coronary syndromes (1297) 1297
risk assessment (1283) 1283
follow-up studies (1265) 1265
density-lipoprotein cholesterol (1252) 1252
enzymes (1236) 1236
physiological aspects (1222) 1222
biomarkers - blood (1165) 1165
safety (1164) 1164
dyslipidemia (1160) 1160
primary prevention (1156) 1156
surgery (1154) 1154
heart (1138) 1138
cholesterol - blood (1135) 1135
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (43518) 43518
German (180) 180
Russian (170) 170
Spanish (117) 117
French (105) 105
Japanese (34) 34
Korean (26) 26
Hungarian (24) 24
Polish (19) 19
Portuguese (13) 13
Czech (11) 11
Croatian (10) 10
Chinese (9) 9
Swedish (9) 9
Turkish (6) 6
Serbian (2) 2
Slovak (2) 2
Ukrainian (2) 2
Dutch (1) 1
Italian (1) 1
Lithuanian (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10088, pp. 2473 - 2481
Summary Background In blinded randomised controlled trials, statin therapy has been associated with few adverse events (AEs). By contrast, in observational... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | CLINICAL-TRIALS | CARDIOVASCULAR-DISEASE | PREVENTION | RISK | INTOLERANCE | PARTICIPANTS | Hematologic Diseases - chemically induced | Hypolipidemic Agents - adverse effects | Atorvastatin - adverse effects | Double-Blind Method | Nocebo Effect | Humans | Middle Aged | Risk Factors | Male | Treatment Outcome | Atorvastatin - administration & dosage | Sleep Wake Disorders | Early Termination of Clinical Trials | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Lymphatic Diseases - chemically induced | Hypolipidemic Agents - administration & dosage | Hypertension - complications | Adult | Female | Hypercholesterolemia - prevention & control | Aged | Muscular Diseases - chemically induced | Clinical trials | Medicine, Experimental | Complications and side effects | Medical research | Epidemiology | Statins | Analysis | Cardiac patients | Sexual disorders | Risk factors | Myocardial infarction | Heart | Therapy | Laboratories | Funding | Physicians | Disorders | Impairment | Cognitive ability | Lipids | Cardiovascular disease | Angina | Matching | Connective tissues | Disturbance | Heart diseases | Public health | Hypertension | Medical personnel | Lymphatic system | Fasting | Effectiveness | Kidneys | Health risks | Erectile dysfunction | Risk analysis | Patients | Low density lipoprotein | Cholesterol | Doctors | Side effects | Sleep | Atorvastatin | Infarction | Health risk assessment | Cardiovascular diseases | Kidney transplantation | Index Medicus | Abridged Index Medicus | Clinical Medicine | management | clinical-trials | intolerance | risk | cardiovascular-disease | Klinisk medicin | General & Internal Medicine | prevention | participants
Journal Article
Circulation, ISSN 0009-7322, 02/2014, Volume 129, Issue 6, pp. 635 - 642
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2017, Volume 377, Issue 12, pp. 1119 - 1131
Patients with myocardial infarction and a high-sensitivity CRP level of 2 mg or more per liter were assigned to one of three canakinumab doses or placebo. The... 
C-REACTIVE PROTEIN | MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | MYOCARDIAL-INFARCTION | STATIN THERAPY | CLONAL HEMATOPOIESIS | INFLAMMATION | CARDIOVASCULAR-DISEASE | INTERLEUKIN-1-BETA INHIBITION | RISK | CORONARY-ARTERY-DISEASE | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Secondary Prevention | Infection - etiology | Incidence | Dose-Response Relationship, Drug | Anti-Inflammatory Agents - adverse effects | C-Reactive Protein - metabolism | Lipids - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Anti-Inflammatory Agents - administration & dosage | Female | Neutropenia - chemically induced | Interleukin-1beta - antagonists & inhibitors | Stroke - prevention & control | Atherosclerosis - drug therapy | Double-Blind Method | Interleukin-1beta - immunology | Atherosclerosis - blood | Myocardial Infarction - drug therapy | Antibodies, Monoclonal - administration & dosage | Aged | Myocardial Infarction - prevention & control | Myocardial infarction | Cerebral infarction | Stroke | Heart attacks | C-reactive protein | Cytokines | Clinical trials | Cardiovascular disease | Innate immunity | Inflammation | Angina | Angina pectoris | Thrombosis | Cholesterol | Disease prevention | Proteins | Arteriosclerosis | Atherosclerosis | Cardiovascular diseases | Health risk assessment | Drug therapy | Drug dosages | Index Medicus | Abridged Index Medicus | Klinisk medicin | Clinical Medicine
Journal Article
Journal Article